Dr Sara Friedl studied biology at the Ludwig-Maximilians-Universität München and obtained her PhD from Technische Universität München in 2013. Her PhD studies at the German Heart Centre Munich involved genome-wide expression analysis of human bypass grafts with different degrees of atherosclerosis. From 2012 to 2015, Sara worked as a post-doctoral associate in the Chen lab at Singapore-MIT-Alliance for Research and Development in Singapore investigating malaria infection in a humanised mouse model.
In October 2016 she has taken over the role as Research Director for the Synthetic Portabolomics Project.
Tel: 0191 208 8176